Binaytara Foundation

Chairperson

Dr. Damiano Rondelli

Dr. Damiano Rondelli is a Professor of Medicine and Director of Stem Cell Transplant Program at the University of Illinois at Chicago.
His clinical research focuses on allogeneic stem cell transplantation. In particular, his interest has been on the use of i.v. busulfan in transplant conditioning regimens, stem cell transplantation in myelofibrosis and identification of biomarkers of acute and chronic GVHD by flow cytometry. His laboratory focuses on in-vitro and in-vivo models of T cell alloreactivity against hematopoietic stem cells and translational strategies to overcome it.

Dr. Rondelli serves as a member of the International Myeloproliferative Disorders Research Consortium (MPD-RC), funded by an NCI PO1 grant (PI Ronald Hoffman, MD) where he chairs a study using a reduced intensity conditioning regimen in allogeneic stem cell transplantation for patients with myelofibrosis.

Dr. Rondelli has published over 90 full-papers in international peer-reviewed journals including Blood, Leukemia, Biology Blood Marrow Transplantation, and is a co-author of an Italian Hematology textbook. “Lezioni di Ematologia” by Sante Tura et al, Esculapio Bologna, 2003. He is a reviewer of many esteemed journals including Blood, Cancer research, American Journal of Transplantation, etc.

Dr. Rondelli received his medical degree with honors from the University of Bologna, Italy. After completing School of specialization in hematology at the University of Bologna, he worked as research associate at the Fred Hutchinson Cancer Research Center, Seattle, WA where he started his studies on the antigen presenting function of CD34+ hematopoetic stem cells.

Members

Dr. Augustus Valmond
Attending, Department of Nephrology, Brooklyn Hospital Center.

Dr. Hemchandra Mahaseth
Fellow, Winship Cancer Institute, Emory University, Atlanta, GA

Dr. Joel Epstein
Professor, University of Illinois, Chicago

Dr. Joel Epstein is Professor in Oral Medicine and Diagnostic Sciences, College of Dentistry and Otolaryngology and Head and Neck Surgery and Cancer Center, College of Medicine at the University of Illinois at Chicago.

His clinical research focuses on oral oncology, including early detection, diagnosis and management of oral premalignant epithelial lesions, and acute and chronic complications of cancer therapy, with a focus on oral mucositis, xerostomia, oral infections, taste, pain and quality of life.

Dr. Epstein is on the Board of Directors of the Multinational Association for Supportive Care in Cancer, a Diplomate of American Board of Oral Medicine, a Fellow of the Royal College of Dentists of Canada (Oral Medicine) and a Fellow of the College of Surgeons of Edinburg.

Dr. Epstein has published over 390 full-papers in international peer-reviewed journals, been editor of two books, including Oral Complications of Cancer and its Management and is Associate Editor of Supportive Care in Cancer, and a reviewer of a number of journals.
Dr. Epstein received his dental degree from the University of Saskatchewan, a residency at the University of Toronto, and graduate training at the University of Washington in Seattle.

Dr. Lawrence Feldman
Associate Professor, Dept. of Medicine (Hematology/Oncology) at University of Illinois at Chicago

Dr. Purvish Parikh
Convener, Indian Cooperative oncology Network ICON ARO
Editor-in-Chief, Indian Journal of Cancer

Dr. Rajesh Dudhani
Fellow, Section of Neonatology, University of Chicago, Chicago, IL.

Dr. Rakesh Mandal
Waisman Center, University of Wisconsin, Madison

Dr. Seshan Subramanian
Chair of the Department of Medicine, Mercy hospital and medical center, Chicago, IL.
Clinical Professor of Medicine, University of Illinois Chicago School of Medicine.

Dr. Sharath Gowda
Dept. of Geriatrics, Staten Island University, NY.

Dr. Yi-Hsiang Chen
Associate Professor, College of Medicine, University of Illinois at Chicago.
CV